Martine A. Rothblatt - 05 Mar 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Reporting relationship
Chairperson & CEO, Director
Issuer ticker
UTHR
Reported as of
05 Mar 2026
Net transaction value
-$4,603,232
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Mar 2026, 16:36:00 UTC
Prior SEC filing
05 Mar 2026
Next SEC filing
10 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John S. Hess, Jr. under Power of Attorney

Key filing fact

Martine A. Rothblatt filed Form 4 for UNITED THERAPEUTICS Corp (UTHR) on 09 Mar 2026.

Key facts

  • This page summarizes Martine A. Rothblatt's Form 4 filing for UNITED THERAPEUTICS Corp (UTHR).
  • 11 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 09 Mar 2026, 16:36.

Change

  • Previous filing in this sequence was filed on 05 Mar 2026.
  • Current net transaction value: -$4,603,232.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001106578 Primary reporting owner

ROTHBLATT MARTINE A

Relationship
Chairperson & CEO, Director
Address
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Signature date
09 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTHR transaction

Common Stock

Options Exercise

Transaction value
Shares
+9,500
Change %
+7308%
Price
$146.03*
Shares after
9,630
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1
UTHR transaction

Common Stock

Sale

Transaction value
$133,889
Shares
-279
Change %
-2.9%
Price
$479.89
Shares after
9,351
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F2
UTHR transaction

Common Stock

Sale

Transaction value
$231,148
Shares
-481
Change %
-5.1%
Price
$480.56
Shares after
8,870
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F3
UTHR transaction

Common Stock

Sale

Transaction value
$245,844
Shares
-510
Change %
-5.7%
Price
$482.05
Shares after
8,360
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F4
UTHR transaction

Common Stock

Sale

Transaction value
$624,422
Shares
-1,293
Change %
-15%
Price
$482.92
Shares after
7,067
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F5
UTHR transaction

Common Stock

Sale

Transaction value
$836,435
Shares
-1,728
Change %
-24%
Price
$484.05
Shares after
5,339
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F6
UTHR transaction

Common Stock

Sale

Transaction value
$1,273,121
Shares
-2,625
Change %
-49%
Price
$485.00
Shares after
2,714
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F7
UTHR transaction

Common Stock

Sale

Transaction value
$387,990
Shares
-798
Change %
-29%
Price
$486.20
Shares after
1,916
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F8
UTHR transaction

Common Stock

Sale

Transaction value
$583,938
Shares
-1,199
Change %
-63%
Price
$487.02
Shares after
717
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F9
UTHR transaction

Common Stock

Sale

Transaction value
$286,445
Shares
-587
Change %
-82%
Price
$487.98
Shares after
130
Date
05 Mar 2026
Ownership
Direct
Footnotes
F1, F10
UTHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
166
Date
05 Mar 2026
Ownership
by Spouse
UTHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
324,518
Date
05 Mar 2026
Ownership
by Trust
Footnotes
F11
UTHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
258,117
Date
05 Mar 2026
Ownership
by Trust
Footnotes
F12
UTHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
45,596
Date
05 Mar 2026
Ownership
by Trust
Footnotes
F13
UTHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,962
Date
05 Mar 2026
Ownership
by Trust
Footnotes
F14

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UTHR transaction Derivative

Stock Options

Options Exercise

Transaction value
Shares
-9,500
Change %
-4.5%
Price
$0.000000*
Shares after
202,000
Date
05 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,500
Exercise price
$146.03
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 14 footnotes

Footnote F1

This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $479.14 to $480.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $480.28 to $481.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

This transaction was executed in multiple trades at prices ranging from $481.52 to $482.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F5

This transaction was executed in multiple trades at prices ranging from $482.52 to $483.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F6

This transaction was executed in multiple trades at prices ranging from $483.53 to $484.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F7

This transaction was executed in multiple trades at prices ranging from $484.61 to $485.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F8

This transaction was executed in multiple trades at prices ranging from $485.61 to $486.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F9

This transaction was executed in multiple trades at prices ranging from $486.62 to $487.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F10

This transaction was executed in multiple trades at prices ranging from $487.67 to $488.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F11

Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

Footnote F12

Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

Footnote F13

Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

Footnote F14

Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .